Method of reducing bacterial activity in the oral cavity of a patient

Patent metadata

Field	Value
Publication number	US-12102697-B2
Application number	US-202318490074-A
Country	US
Kind code	B2
Filing date	Oct 19, 2023
Priority date	Dec 8, 2020
Publication date	Oct 1, 2024
Grant date	Oct 1, 2024

Abstract

Base material arrangements having at least two layers can accommodate the addition of antifungal material (nanofiller), such as in denture base resin without significantly compromising the mechanical properties and/or translucency of the base material arrangements. Antifungal agents such as nanosilver and nanozirconia can be used to modify a surface layer of the material arrangements, such as the denture base, to overcome certain known shortcomings of the modified materials, e.g., typical acrylic resins containing nanosilver and nanozirconia.

First claim

The invention claimed is:

1. A method of reducing bacterial activity in an oral cavity of a patient having a dental appliance, comprising:
fitting the patient with an antibacterial denture;
wherein the antibacterial denture has a polished cameo surface and an unpolished intaglio surface made of a dental restoration base material,
wherein the dental restoration base material comprises:
a first layer comprising at least 90 wt. %, relative to total first layer weight, of a cured first composition comprising, prior to curing, a first (meth)acrylic polymer and a first (meth)acrylic monomer as the cameo surface of the antibacterial denture; and
a surface layer comprising at least 90 wt. %, relative to total surface layer weight, of a cured second composition comprising, prior to curing, a second (meth)acrylic polymer, a second (meth)acrylic monomer as the intaglio surface of the antibacterial denture, and 0.45 to 0.55 wt. % of antimicrobial nanoparticles, relative to a total surface layer weight,

wherein no gradient in antimicrobial nanoparticle content and no continuous bulk containing the antimicrobial nanoparticles is present between the first and surface layers,
wherein the first layer is free of the antimicrobial nanoparticles,
wherein the antimicrobial nanoparticles are selected from silver nanoparticles and zirconium dioxide nanoparticles, and
wherein the material has a flexural strength in a range of 78 to 87 MPa, a translucency parameter in a range of 6.5 to 13, and a surface roughness in a range of 0.13 to 0.2 μm.

2. The method of claim 1 , wherein the silver nanoparticles have an average particle size of 5 to 40 nm.

3. The method of claim 1 , wherein the zirconium dioxide nanoparticles have an average particle size of 20 to 60 nm.

4. The method of claim 1 , wherein the surface layer directly contacts the first layer on at least portions of the first layer.

5. The method of claim 1 , wherein the surface layer has a thickness of 100 to 3,000 μm.

6. The method of claim 1 , wherein the first (meth)acrylic polymer and the second (meth)acrylic polymer each comprise at least 90 wt. % poly(methyl methacrylate).

7. The method of claim 1 , wherein the first (meth)acrylic monomer and the second (meth)acrylic monomer each comprise at least 90 wt. % methyl methacrylate.

8. The method of claim 1 , wherein the first (meth)acrylic polymer and the second (meth)acrylic polymer are the same,
wherein the first (meth)acrylic monomer and the second (meth)acrylic monomer are the same, and
wherein the first and the second (meth)acrylic monomer are suitable to form the same polymer as the first and the second (meth)acrylic polymer.

9. The method of claim 1 , which is suitable to reduce Candida adhesion by at least 10%, relative to materials comprising the first layer alone.

Assignees

• Univ Imam Abdulrahman Bin Faisal

Inventors

• Gad Mohammed Moustafa Ahmed
• Abualsaud Reem
• Rahoma Ahmed Mohamed
• Fouda Shaimaa Mohamed Said
• Al-Thobity Ahmad M

Classifications

• C08K3/015

  Biocides (macromolecular substances as carriers for biocide material A01N25/10) · CPC title

• C08K2003/0806

  Silver · CPC title

• C08K2201/011

  Nanostructured additives · CPC title

• B82Y5/00

  Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery · CPC title

• C08K3/22

  of metals · CPC title